Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2170806 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MAPTNPSR1GAAL3MBTL1 | |
| SCHEMBL16711824 | 0.83 | ALDH1A1 (0.52) | ALDH1A1MAPTNPSR1GAAL3MBTL1 | |
| SCHEMBL16711821 | 0.83 | ALDH1A1 (0.52) | ALDH1A1MAPTNPSR1GAAL3MBTL1 | |
| SCHEMBL2171549 | 0.79 | NPSR1 (0.62) | ALDH1A1MAPTNPSR1GAAKMT2A | |
| SCHEMBL2171546 | 0.79 | NPSR1 (0.62) | ALDH1A1MAPTNPSR1GAAKMT2A | |
| SCHEMBL2169932 | 0.77 | ALDH1A1 (0.55) | ALDH1A1MAPTNPSR1GAAKMT2A | |
| SCHEMBL2169928 | 0.77 | ALDH1A1 (0.55) | ALDH1A1MAPTNPSR1GAAKMT2A | |
| SCHEMBL2359520 | 0.76 | ALDH1A1 (0.42) | ALDH1A1MAPTNPSR1GAAL3MBTL1 | |
| SCHEMBL29213677 | 0.76 | ALDH1A1 (0.54) | ALDH1A1MAPTNPSR1GAAL3MBTL1 | |
| SCHEMBL30861678 | 0.76 | ALDH1A1 (0.54) | ALDH1A1MAPTNPSR1GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195930-A1 | PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2011-08-11 | — | — | US | disclosed |
| EP-2346851-A2 | PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010055896-A2 | PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2010-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195930-A1 | PYRIDINE DERIVATIVE OR ITS SALT, PESTICIDE CONTAINING IT AND PROCESS FOR ITS PRODUCTION | NOX3, SCN3A, OR10J3 | ALDH1A1 1408/4885MAPT 3350/4885NPSR1 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.